[精品]美沙拉秦、布拉氏酵母菌散和康复新液三联疗法治疗溃疡性结肠炎的效果.doc

《[精品]美沙拉秦、布拉氏酵母菌散和康复新液三联疗法治疗溃疡性结肠炎的效果.doc》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。

1、美沙拉秦、布拉氏酵母菌散和康复新液三联疗法治疗溃疡性结肠炎的效果美沙拉秦、布拉氏酵母菌散和康复新液三联疗法治疗溃疡性结肠炎的效果［摘要］冃的探讨对美沙拉秦肠溶片、布拉氏酵母菌散和康复新液治疗溃疡性结肠炎的临床效果，为合理选择纱物提供参考。方法选择2012年1月〜2013年12月河北北方学院附属第三医院消化科门诊和住院部确诊为轻、中度溃疡性结肠炎患者70例，随机分为治疗组和对照组，每组各35例。治疗组选用口服美沙拉秦肠溶片，布拉氏酵母菌散，将50mL康复新原液加温至37〜40°C，保留灌肠，每晚1次；对照组选用口服美沙拉秦肠溶片的方法进行治疗，比较两组患者的临床疗效。结果治疗

2、6周后观察，治疗组患者腹痛、腹泻、黏液脓血便及大便次数等症状均比单服美沙拉秦肠溶片对照组患者明显改善，差异有统计学意义(P<0.05)o治疗组完全缓解24例,有效7例，无效4例，总有效率为89%；对照组完全缓解14例，有效1例，无效20例，总有效率为43%,两组治疗效果比较，差异有统计学意义(P<0.05)o结论美沙拉秦肠溶片、布拉氏酵母菌散和康复新液治疗溃疡性结肠炎疗效确切，值得在临床推广应用。［关键词］美沙拉秦肠溶片；布拉氏酵母菌散；康复新液；溃疡性结肠炎［中图分类号］R574.63［文献标识码］A［文章编号］1673-7210(2014)08(a)-0066-04Th

3、erapeuticeffectofMesalazineTablet,SaccharomycesBoulardiiSachetandKangfuxinSolutionintreatingulcerativecolitisLIJianjunlGUOLianfenglLIJianpinglSIShuwei2HANZhihonglLIUFengxianl1・DepartmentofGastroenterology,theThirdAffiliatedHospitalofHebeiNorthernInstitute,HebeiProvince,Zhangjiakou075000,Ch

4、ina；2.DepartmentofGastroenterology,KailuanGroupYuzhouMiningIndustryCompanyHospital,HebeiProvince,Zhangjiakou075000,China[Abstract]ObjectiveToinvestigatetheclinicalefficacyofMesalazineEnteric-coatedTablet,SaccharomycesBoulardiiSachetandKangfuxinSolutionintreatingulcerativecolitis,andprovide

5、areferenceforareasonablechoiceofdrugs・Methods70outpatientsandinpatientswithmild-moderateulcerativecolitisinDepartmentofGastroenterology,theThirdAffiliatedHospitalofHebeiNorthernInstitute,fromJanuary2012toDecember2013,wererandomlydividedintothetreatmentgroup(35cases)andthecontrolgroup(35cas

6、s)・ThetreatmentgroupweregivenMesalazineEnteric-coatedTablet,SaccharomycesBoulardiiSachetandKangfuxinSolution(50mL)in37-40°Cforretention-enemaonceaday,whilethecontrolgroupwasgivenMesalazineEnteric-coatedTabletonly.Theclinicaleffectwascompared.ResultsTheclinicalsymptomsofabdominalpain,diarrh

7、ea,mucousstoolwithpusandblood,stoolfrequencyandsoonintreatmentgroup6weeksafterthetreatmentwereallbetterthanthoseincontrolgroup,thedifferenceswerestatisticallysignificant(P<0.05)・Intreatmentgroup,24caseswereremarkablyeffective,7caseswereeffective,4caseswereinef